CAR T cells from code to clinic: Framing modeling approaches with current translational research goals
Cell Systems · 2026-10 · 17 (10) · 101716
DOI: 10.1016/j.cels.2026.101716 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Systems, 2026-10. Verfasst von Lucas E Sant'Anna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford,…. Hauptthemen laut MEDLINE: Translational Research, Biomedical, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 198 Literaturangaben. Gefördert von: National Science Foundation, Stanford University, National Science Foundation Graduate Research Fellowship Program.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T cell therapy has transformed treatment of resistant cancers, yet it faces major limitations such as variable patient responses, relapse, and safety issues. Optimizing CAR T cell treatment regimens and genetic design could offer solutions to some of these problems, but the resulting design space is often too large to explore experimentally alone. Mathematical modeling-spanning ordinary differential equation (ODE), agent-based, statistical, and machine learning methods-provides a framework to link mechanistic understanding of CAR T cells to predictive design and clinical decision-making. Here, we present a perspective that organizes modeling approaches around key translational challenges in CAR T therapy, evaluating the strengths, limitations, and data gaps of current approaches. We outline a roadmap for clinicians and modelers alike, highlighting advances in machine learning, multiscale modeling, control theory, and alternative cell types as emerging opportunities in model-guided design of next-generation cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Mechanical Engineering, Stanford Univers…
- Department of Mechanical Engineering, Stanford University, Stanford, CA 94305, USA.
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; Department of Mechanical Engineering, Stanford University, Stanford, CA 94305, USA. Electronic address: mmayalu@stanford.edu.
Förderung
- National Science Foundation
- Stanford University
- National Science Foundation Graduate Research Fellowship Program
Zitieren
APA
Sant'Anna, L. E., Roy, R., Schwab, J. C., Perez, J. I., & Mayalu, M. N. (2026). CAR T cells from code to clinic: Framing modeling approaches with current translational research goals. Cell Systems, 17(10), 101716. https://doi.org/10.1016/j.cels.2026.101716
Vancouver
Sant'Anna LE, Roy R, Schwab JC, Perez JI, Mayalu MN. CAR T cells from code to clinic: Framing modeling approaches with current translational research goals. Cell Systems. 2026;17(10):101716. doi:10.1016/j.cels.2026.101716
BibTeX
@article{SantAnna2026,
author = {Sant'Anna, Lucas E and Roy, Rohita and Schwab, Janella C and Perez, Julian I and Mayalu, Michaëlle N},
title = {CAR T cells from code to clinic: Framing modeling approaches with current translational research goals},
journal = {Cell Systems},
year = {2026},
volume = {17},
number = {10},
pages = {101716},
doi = {10.1016/j.cels.2026.101716}
}
EUVIMED